BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Weiss AA, Babyatsky MW, Ogata S, Chen A, Itzkowitz SH. Expression of MUC2 and MUC3 mRNA in human normal, malignant, and inflammatory intestinal tissues. J Histochem Cytochem. 1996;44:1161-1166. [PMID: 8813081 DOI: 10.1177/44.10.8813081] [Cited by in Crossref: 73] [Cited by in F6Publishing: 77] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Reynolds KL, Cloft SE, Wong EA. Changes with age in density of goblet cells in the small intestine of broiler chicks. Poult Sci 2020;99:2342-8. [PMID: 32359569 DOI: 10.1016/j.psj.2019.12.052] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
2 De Carlo F, Witte TR, Hardman WE, Claudio PP. Omega-3 eicosapentaenoic acid decreases CD133 colon cancer stem-like cell marker expression while increasing sensitivity to chemotherapy. PLoS One 2013;8:e69760. [PMID: 23874993 DOI: 10.1371/journal.pone.0069760] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 5.1] [Reference Citation Analysis]
3 Yao T, Takata M, Tustsumi S, Nishiyama K, Taguchi K, Nagai E, Tsuneyoshi M. Phenotypic expression of gastrointestinal differentiation markers in colorectal adenocarcinomas with liver metastasis. Pathology. 2002;34:556-560. [PMID: 12555994 DOI: 10.1080/0031302021000035965-4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
4 Olli KE, Rapp C, O'Connell L, Collins CB, McNamee EN, Jensen O, Jedlicka P, Allison KC, Goldberg MS, Gerich ME, Frank DN, Ir D, Robertson CE, Evans CM, Aherne CM. Muc5ac Expression Protects the Colonic Barrier in Experimental Colitis. Inflamm Bowel Dis 2020;26:1353-67. [PMID: 32385500 DOI: 10.1093/ibd/izaa064] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
5 Ohlsson L, Hammarström ML, Israelsson A, Näslund L, Oberg A, Lindmark G, Hammarström S. Biomarker selection for detection of occult tumour cells in lymph nodes of colorectal cancer patients using real-time quantitative RT-PCR. Br J Cancer 2006;95:218-25. [PMID: 16755296 DOI: 10.1038/sj.bjc.6603206] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
6 Hugen N, Brown G, Glynne-Jones R, de Wilt JH, Nagtegaal ID. Advances in the care of patients with mucinous colorectal cancer. Nat Rev Clin Oncol 2016;13:361-9. [PMID: 26323388 DOI: 10.1038/nrclinonc.2015.140] [Cited by in Crossref: 88] [Cited by in F6Publishing: 77] [Article Influence: 14.7] [Reference Citation Analysis]
7 Forsberg G, Fahlgren A, Hörstedt P, Hammarström S, Hernell O, Hammarström ML. Presence of bacteria and innate immunity of intestinal epithelium in childhood celiac disease. Am J Gastroenterol. 2004;99:894-904. [PMID: 15128357 DOI: 10.1111/j.1572-0241.2004.04157.x] [Cited by in Crossref: 108] [Cited by in F6Publishing: 103] [Article Influence: 6.4] [Reference Citation Analysis]
8 Liu J, Walker NM, Ootani A, Strubberg AM, Clarke LL. Defective goblet cell exocytosis contributes to murine cystic fibrosis-associated intestinal disease. J Clin Invest. 2015;125:1056-1068. [PMID: 25642775 DOI: 10.1172/jci73193] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
9 Amano Y, Ishihara S, Kushiyama Y, Yuki T, Takahashi Y, Chinuki D, Miyake T, Miyaoka Y, Rumi MA, Ishimura N, Adachi K, Kinoshita Y. Barrett's oesophagus with predominant intestinal metaplasia correlates with superficial cyclo-oxygenase-2 expression, increased proliferation and reduced apoptosis: changes that are partially reversed by non-steroidal anti-inflammatory drugs usage. Aliment Pharmacol Ther 2004;20:793-802. [PMID: 15379840 DOI: 10.1111/j.1365-2036.2004.02195.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
10 Kumar P, Kuhlmann FM, Bhullar K, Yang H, Vallance BA, Xia L, Luo Q, Fleckenstein JM. Dynamic Interactions of a Conserved Enterotoxigenic Escherichia coli Adhesin with Intestinal Mucins Govern Epithelium Engagement and Toxin Delivery. Infect Immun 2016;84:3608-17. [PMID: 27736776 DOI: 10.1128/IAI.00692-16] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
11 Molaei M, Mansoori BK, Mashayekhi R, Vahedi M, Pourhoseingholi MA, Fatemi SR, Zali MR. Mucins in neoplastic spectrum of colorectal polyps: can they provide predictions? BMC Cancer 2010;10:537. [PMID: 20929551 DOI: 10.1186/1471-2407-10-537] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
12 Niv Y. Mucin gene expression in the intestine of ulcerative colitis patients: a systematic review and meta-analysis. European Journal of Gastroenterology & Hepatology 2016;28:1241-5. [DOI: 10.1097/meg.0000000000000707] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
13 Longman RJ, Poulsom R, Corfield AP, Warren BF, Wright NA, Thomas MG. Alterations in the composition of the supramucosal defense barrier in relation to disease severity of ulcerative colitis. J Histochem Cytochem. 2006;54:1335-1348. [PMID: 16924127 DOI: 10.1369/jhc.5a6904.2006] [Cited by in Crossref: 51] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
14 Matsuoka Y, Pascall JC, Brown KD. Quantitative analysis reveals differential expression of mucin (MUC2) and intestinal trefoil factor mRNAs along the longitudinal axis of rat intestine. Biochim Biophys Acta. 1999;1489:336-344. [PMID: 10673034 DOI: 10.1016/s0167-4781(99)00186-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
15 Sheng YH, Hasnain SZ, Florin TH, McGuckin MA. Mucins in inflammatory bowel diseases and colorectal cancer. J Gastroenterol Hepatol. 2012;27:28-38. [PMID: 21913981 DOI: 10.1111/j.1440-1746.2011.06909.x] [Cited by in Crossref: 108] [Cited by in F6Publishing: 98] [Article Influence: 12.0] [Reference Citation Analysis]
16 Yao T, Utsunomiya T, Oya M, Nishiyama K, Tsuneyoshi M. Extremely well-differentiated adenocarcinoma of the stomach: clinicopathological and immunohistochemical features. World J Gastroenterol. 2006;12:2510-2516. [PMID: 16688795 DOI: 10.3748/wjg.v12.i16.2510] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
17 Faure M, Mettraux C, Moennoz D, Godin JP, Vuichoud J, Rochat F, Breuillé D, Obled C, Corthésy-Theulaz I. Specific amino acids increase mucin synthesis and microbiota in dextran sulfate sodium-treated rats. J Nutr 2006;136:1558-64. [PMID: 16702321 DOI: 10.1093/jn/136.6.1558] [Cited by in Crossref: 95] [Cited by in F6Publishing: 85] [Article Influence: 6.3] [Reference Citation Analysis]
18 Augenlicht L, Shi L, Mariadason J, Laboisse C, Velcich A. Repression of MUC2 gene expression by butyrate, a physiological regulator of intestinal cell maturation. Oncogene 2003;22:4983-92. [PMID: 12902981 DOI: 10.1038/sj.onc.1206521] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 2.4] [Reference Citation Analysis]
19 Levi GS, Harpaz N. Intestinal low-grade tubuloglandular adenocarcinoma in inflammatory bowel disease. Am J Surg Pathol. 2006;30:1022-1029. [PMID: 16861975 DOI: 10.1097/00000478-200608000-00014] [Cited by in Crossref: 57] [Cited by in F6Publishing: 35] [Article Influence: 3.8] [Reference Citation Analysis]
20 Yu F, Huang L, Shen F, Wu S, Chen J. Prognostic implications of mucinous histology in stage III colon cancer with the receipt of adjuvant chemotherapy. J Gastrointest Oncol 2020;11:858-69. [PMID: 33209482 DOI: 10.21037/jgo-20-160] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Yamaguchi K, Cekanova M, McEntee MF, Yoon JH, Fischer SM, Renes IB, Van Seuningen I, Baek SJ. Peroxisome proliferator-activated receptor ligand MCC-555 suppresses intestinal polyps in ApcMin/+ mice via extracellular signal-regulated kinase and peroxisome proliferator-activated receptor-dependent pathways. Mol Cancer Ther 2008;7:2779-87. [PMID: 18790758 DOI: 10.1158/1535-7163.MCT-08-0173] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
22 Hugen N, Simons M, Halilović A, van der Post RS, Bogers AJ, Marijnissen-van Zanten MA, de Wilt JH, Nagtegaal ID. The molecular background of mucinous carcinoma beyond MUC2. J Pathol Clin Res 2015;1:3-17. [PMID: 27499889 DOI: 10.1002/cjp2.1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
23 Shigemura H, Ishiguro N, Inoshima Y. Up-regulation of MUC2 mucin expression by serum amyloid A3 protein in mouse colonic epithelial cells. J Vet Med Sci 2014;76:985-91. [PMID: 24694941 DOI: 10.1292/jvms.14-0007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
24 Grondin JA, Kwon YH, Far PM, Haq S, Khan WI. Mucins in Intestinal Mucosal Defense and Inflammation: Learning From Clinical and Experimental Studies. Front Immunol 2020;11:2054. [PMID: 33013869 DOI: 10.3389/fimmu.2020.02054] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 22.0] [Reference Citation Analysis]
25 Luo C, Cen S, Ding G, Wu W. Mucinous colorectal adenocarcinoma: clinical pathology and treatment options. Cancer Commun (Lond). 2019;39:13. [PMID: 30922401 DOI: 10.1186/s40880-019-0361-0] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 26.5] [Reference Citation Analysis]
26 Mack DR, McDonald TL, Larson MA, Wei S, Weber A. The conserved TFLK motif of mammary-associated serum amyloid A3 is responsible for up-regulation of intestinal MUC3 mucin expression in vitro. Pediatr Res 2003;53:137-42. [PMID: 12508093 DOI: 10.1203/00006450-200301000-00023] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
27 Faure M, Moënnoz D, Montigon F, Mettraux C, Breuillé D, Ballèvre O. Dietary threonine restriction specifically reduces intestinal mucin synthesis in rats. J Nutr 2005;135:486-91. [PMID: 15735082 DOI: 10.1093/jn/135.3.486] [Cited by in Crossref: 113] [Cited by in F6Publishing: 95] [Article Influence: 7.1] [Reference Citation Analysis]
28 Walsh MD, Clendenning M, Williamson E, Pearson SA, Walters RJ, Nagler B, Packenas D, Win AK, Hopper JL, Jenkins MA, Haydon AM, Rosty C, English DR, Giles GG, McGuckin MA, Young JP, Buchanan DD. Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype. Mod Pathol 2013;26:1642-56. [PMID: 23807779 DOI: 10.1038/modpathol.2013.101] [Cited by in Crossref: 89] [Cited by in F6Publishing: 82] [Article Influence: 11.1] [Reference Citation Analysis]
29 Liu X, Beaumont M, Walker F, Chaumontet C, Andriamihaja M, Matsumoto H, Khodorova N, Lan A, Gaudichon C, Benamouzig R, Tomé D, Davila AM, Marie JC, Blachier F. Beneficial effects of an amino acid mixture on colonic mucosal healing in rats. Inflamm Bowel Dis 2013;19:2895-905. [PMID: 24193156 DOI: 10.1097/01.MIB.0000435849.17263.c5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 2.9] [Reference Citation Analysis]
30 Corfield AP. The Interaction of the Gut Microbiota with the Mucus Barrier in Health and Disease in Human. Microorganisms 2018;6:E78. [PMID: 30072673 DOI: 10.3390/microorganisms6030078] [Cited by in Crossref: 56] [Cited by in F6Publishing: 40] [Article Influence: 18.7] [Reference Citation Analysis]
31 Liu F, Li G, Wen K, Bui T, Cao D, Zhang Y, Yuan L. Porcine small intestinal epithelial cell line (IPEC-J2) of rotavirus infection as a new model for the study of innate immune responses to rotaviruses and probiotics. Viral Immunol 2010;23:135-49. [PMID: 20373994 DOI: 10.1089/vim.2009.0088] [Cited by in Crossref: 98] [Cited by in F6Publishing: 87] [Article Influence: 8.9] [Reference Citation Analysis]
32 Li Y, Zhang Y, Zhang XL, Feng XY, Liu CZ, Zhang XN, Quan ZS, Yan JT, Zhu JX. Dopamine promotes colonic mucus secretion through dopamine D5 receptor in rats. Am J Physiol Cell Physiol 2019;316:C393-403. [PMID: 30624983 DOI: 10.1152/ajpcell.00261.2017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
33 Williams SJ, Wreschner DH, Tran M, Eyre HJ, Sutherland GR, McGuckin MA. Muc13, a novel human cell surface mucin expressed by epithelial and hemopoietic cells. J Biol Chem. 2001;276:18327-18336. [PMID: 11278439 DOI: 10.1074/jbc.m008850200] [Cited by in Crossref: 202] [Cited by in F6Publishing: 80] [Article Influence: 10.1] [Reference Citation Analysis]
34 Pothuraju R, Krishn SR, Gautam SK, Pai P, Ganguly K, Chaudhary S, Rachagani S, Kaur S, Batra SK. Mechanistic and Functional Shades of Mucins and Associated Glycans in Colon Cancer. Cancers (Basel) 2020;12:E649. [PMID: 32168759 DOI: 10.3390/cancers12030649] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 10.0] [Reference Citation Analysis]
35 Cao Y, Blohm D, Ghadimi BM, Stosiek P, Xing PX, Karsten U. Mucins (MUC1 and MUC3) of gastrointestinal and breast epithelia reveal different and heterogeneous tumor-associated aberrations in glycosylation. J Histochem Cytochem. 1997;45:1547-1557. [PMID: 9358856 DOI: 10.1177/002215549704501111] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 2.0] [Reference Citation Analysis]
36 Prakash R, Bharathi Raja S, Devaraj H, Devaraj SN. Up-regulation of MUC2 and IL-1β expression in human colonic epithelial cells by Shigella and its interaction with mucins. PLoS One 2011;6:e27046. [PMID: 22073249 DOI: 10.1371/journal.pone.0027046] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
37 Yao T, Kajiwara M, Kuroiwa S, Iwashita A, Oya M, Kabashima A, Tsuneyoshi M. Malignant transformation of gastric hyperplastic polyps: Alteration of phenotypes, proliferative activity, and p53 expression. Human Pathology 2002;33:1016-22. [DOI: 10.1053/hupa.2002.126874] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
38 Ogata S, Koganty R, Reddish M, Longenecker BM, Chen A, Perez C, Itzkowitz SH. Different modes of sialyl-Tn expression during malignant transformation of human colonic mucosa. Glycoconj J 1998;15:29-35. [PMID: 9530954 DOI: 10.1023/a:1006935331756] [Cited by in Crossref: 41] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
39 Tatsumi N, Kushima R, Vieth M, Mukaisho K, Kakinoki R, Okabe H, Borchard F, Stolte M, Okanoue T, Hattori T. Cytokeratin 7/20 and mucin core protein expression in ulcerative colitis-associated colorectal neoplasms. Virchows Arch. 2006;448:756-762. [PMID: 16609910 DOI: 10.1007/s00428-006-0188-3] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
40 Buisine MP, Desreumaux P, Leteurtre E, Copin MC, Colombel JF, Porchet N, Aubert JP. Mucin gene expression in intestinal epithelial cells in Crohn's disease. Gut 2001;49:544-51. [PMID: 11559653 DOI: 10.1136/gut.49.4.544] [Cited by in Crossref: 104] [Cited by in F6Publishing: 99] [Article Influence: 5.2] [Reference Citation Analysis]
41 Börger ME, Gosens MJ, Jeuken JW, van Kempen LC, van de Velde CJ, van Krieken JH, Nagtegaal ID. Signet ring cell differentiation in mucinous colorectal carcinoma. J Pathol 2007;212:278-86. [PMID: 17471475 DOI: 10.1002/path.2181] [Cited by in Crossref: 59] [Cited by in F6Publishing: 50] [Article Influence: 4.2] [Reference Citation Analysis]
42 Limage R, Tako E, Kolba N, Guo Z, García-Rodríguez A, Marques CNH, Mahler GJ. TiO2 Nanoparticles and Commensal Bacteria Alter Mucus Layer Thickness and Composition in a Gastrointestinal Tract Model. Small 2020;16:e2000601. [PMID: 32338455 DOI: 10.1002/smll.202000601] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
43 Shirazi T, Longman RJ, Corfield AP, Probert CS. Mucins and inflammatory bowel disease. Postgrad Med J. 2000;76:473-478. [PMID: 10908374 DOI: 10.1136/pmj.76.898.473] [Cited by in Crossref: 98] [Cited by in F6Publishing: 92] [Article Influence: 4.7] [Reference Citation Analysis]
44 Ou G, Baranov V, Lundmark E, Hammarström S, Hammarström ML. Contribution of intestinal epithelial cells to innate immunity of the human gut--studies on polarized monolayers of colon carcinoma cells. Scand J Immunol 2009;69:150-61. [PMID: 19170965 DOI: 10.1111/j.1365-3083.2008.02208.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
45 Duncan TJ, Watson NF, Al-Attar AH, Scholefield JH, Durrant LG. The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer. World J Surg Oncol. 2007;5:31. [PMID: 17349047 DOI: 10.1186/1477-7819-5-31] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 3.2] [Reference Citation Analysis]
46 Yao T, Tsutsumi S, Akaiwa Y, Takata M, Nishiyama K, Kabashima A, Tsuneyoshi M. Phenotypic expression of colorectal adenocarcinomas with reference to tumor development and biological behavior. Jpn J Cancer Res. 2001;92:755-761. [PMID: 11473726 DOI: 10.1111/j.1349-7006.2001.tb01158.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
47 Zhou YW, Long YX, Chen Y, Liu JY, Pu D, Huang JY, Bi F, Li Q, Gou HF, Qiu M. First-line therapy of bevacizumab plus chemotherapy versus cetuximab plus chemotherapy for metastatic colorectal cancer patients with mucinous adenocarcinoma or mucinous component. Cancer Med 2021;10:3388-402. [PMID: 33939281 DOI: 10.1002/cam4.3876] [Reference Citation Analysis]
48 Buisine MP, Desreumaux P, Debailleul V, Gambiez L, Geboes K, Ectors N, Delescaut MP, Degand P, Aubert JP, Colombel JF, Porchet N. Abnormalities in mucin gene expression in Crohn's disease. Inflamm Bowel Dis 1999;5:24-32. [PMID: 10028446 DOI: 10.1097/00054725-199902000-00004] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 2.3] [Reference Citation Analysis]
49 Sylvester PA, Myerscough N, Warren BF, Carlstedt I, Corfield AP, Durdey P, Thomas MG. Differential expression of the chromosome 11 mucin genes in colorectal cancer. J Pathol. 2001;195:327-335. [PMID: 11673830 DOI: 10.1002/path.951] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 2.3] [Reference Citation Analysis]
50 Delker DA, McGettigan BM, Kanth P, Pop S, Neklason DW, Bronner MP, Burt RW, Hagedorn CH. RNA sequencing of sessile serrated colon polyps identifies differentially expressed genes and immunohistochemical markers. PLoS One 2014;9:e88367. [PMID: 24533081 DOI: 10.1371/journal.pone.0088367] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 6.0] [Reference Citation Analysis]
51 Nutten S, Sansonetti P, Huet G, Bourdon-Bisiaux C, Meresse B, Colombel JF, Desreumaux P. Epithelial inflammation response induced by Shigella flexneri depends on mucin gene expression. Microbes Infect 2002;4:1121-4. [PMID: 12361911 DOI: 10.1016/s1286-4579(02)01636-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
52 Damiano S, Morano A, Ucci V, Accetta R, Mondola P, Paternò R, Avvedimento VE, Santillo M. Dual oxidase 2 generated reactive oxygen species selectively mediate the induction of mucins by epidermal growth factor in enterocytes. The International Journal of Biochemistry & Cell Biology 2015;60:8-18. [DOI: 10.1016/j.biocel.2014.12.014] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
53 Gratchev A, Siedow A, Bumke-vogt C, Hummel M, Foss H, Hanski M, Kobalz U, Mann B, Lammert H, Stein H, Riecken EO, Hanski C, Mansmann U. Regulation of the intestinal mucin MUC2 gene expression in vivo: evidence for the role of promoter methylation. Cancer Letters 2001;168:71-80. [DOI: 10.1016/s0304-3835(01)00498-0] [Cited by in Crossref: 29] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
54 Corfield AP, Myerscough N, Longman R, Sylvester P, Arul S, Pignatelli M. Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease. Gut. 2000;47:589-594. [PMID: 10986224 DOI: 10.1136/gut.47.4.589] [Cited by in Crossref: 237] [Cited by in F6Publishing: 215] [Article Influence: 11.3] [Reference Citation Analysis]
55 Perez RO, Bresciani BH, Bresciani C, Proscurshim I, Kiss D, Gama-Rodrigues J, Pereira DD, Rawet V, Cecconnello I, Habr-Gama A. Mucinous colorectal adenocarcinoma: influence of mucin expression (Muc1, 2 and 5) on clinico-pathological features and prognosis. Int J Colorectal Dis. 2008;23:757-765. [PMID: 18458918 DOI: 10.1007/s00384-008-0486-0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
56 Wasserberg N, Salgar SK, Yang D, Ruiz P, Ho SB, De Faria WL, Santiago SF, Gandia CE, Miller J, Niv Y, Tzakis AG. Expression of MUC2 and MUC4 proteins and cytokines: early markers of intestinal graft rejection. Transplantation 2003;75:1249-55. [PMID: 12717211 DOI: 10.1097/01.TP.0000060566.34001.CA] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
57 Aksoy N, Corfield AP, Sheehan JK. Preliminary study pointing out a significant alteration in the biochemical composition of MUC2 in colorectal mucinous carcinoma. Clinical Biochemistry 2000;33:167-73. [DOI: 10.1016/s0009-9120(00)00058-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
58 Hanski C, Born M, Foss HD, Marowski B, Mansmann U, Arastéh K, Bachler B, Papenfuss M, Niedobitek F. Defective post-transcriptional processing of MUC2 mucin in ulcerative colitis and in Crohn's disease increases detectability of the MUC2 protein core. J Pathol 1999;188:304-11. [PMID: 10419600 DOI: 10.1002/(SICI)1096-9896(199907)188:3<304::AID-PATH375>3.0.CO;2-A] [Cited by in Crossref: 29] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
59 Imura J, Hayashi S, Ichikawa K, Miwa S, Nakajima T, Nomoto K, Tsuneyama K, Nogami T, Saitoh H, Fujimori T. Malignant transformation of hyperplastic gastric polyps: An immunohistochemical and pathological study of the changes of neoplastic phenotype. Oncol Lett. 2014;7:1459-1463. [PMID: 24765156 DOI: 10.3892/ol.2014.1932] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
60 Sicard JF, Le Bihan G, Vogeleer P, Jacques M, Harel J. Interactions of Intestinal Bacteria with Components of the Intestinal Mucus. Front Cell Infect Microbiol 2017;7:387. [PMID: 28929087 DOI: 10.3389/fcimb.2017.00387] [Cited by in Crossref: 149] [Cited by in F6Publishing: 121] [Article Influence: 37.3] [Reference Citation Analysis]
61 Longman RJ, Douthwaite J, Sylvester PA, O'Leary D, Warren BF, Corfield AP, Thomas MG. Lack of mucin MUC5AC field change expression associated with tubulovillous and villous colorectal adenomas. J Clin Pathol 2000;53:100-4. [PMID: 10767823 DOI: 10.1136/jcp.53.2.100] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
62 Raja SB, Murali MR, Devaraj H, Devaraj SN. Differential expression of gastric MUC5AC in colonic epithelial cells: TFF3-wired IL1 β/Akt crosstalk-induced mucosal immune response against Shigella dysenteriae infection. Journal of Cell Science 2012;125:703-13. [DOI: 10.1242/jcs.092148] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
63 Itoh H, Beck PL, Inoue N, Xavier R, Podolsky DK. A paradoxical reduction in susceptibility to colonic injury upon targeted transgenic ablation of goblet cells. J Clin Invest 1999;104:1539-47. [PMID: 10587517 DOI: 10.1172/JCI6211] [Cited by in Crossref: 48] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
64 Ouwehand AC, Tuomola EM, Kun Lee Y, Salminen S. [13] Microbial interactions to intestinal mucosal models. Microbial Growth in Biofilms - Part B: Special Environments and Physicochemical Aspects. Elsevier; 2001. pp. 200-12. [DOI: 10.1016/s0076-6879(01)37015-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
65 Catalano V, Bergamo F, Cremolini C, Vincenzi B, Negri F, Giordani P, Alessandroni P, Intini R, Stragliotto S, Rossini D, Borelli B, Santini D, Sarti D, Rocchi MBL, Lonardi S, Falcone A, Zagonel V, Mattioli R, Graziano F. Clinical impact of first-line bevacizumab plus chemotherapy in metastatic colorectal cancer of mucinous histology: a multicenter, retrospective analysis on 685 patients. J Cancer Res Clin Oncol 2020;146:493-501. [DOI: 10.1007/s00432-019-03077-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
66 Matsuda K, Yamauchi K, Matsumoto T, Sano K, Yamaoka Y, Ota H. Quantitative analysis of the effect of Helicobacter pylori on the expressions of SOX2, CDX2, MUC2, MUC5AC, MUC6, TFF1, TFF2, and TFF3 mRNAs in human gastric carcinoma cells. Scand J Gastroenterol. 2008;43:25-33. [PMID: 18938748 DOI: 10.1080/00365520701579795] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
67 Johansson ME, Hansson GC. Immunological aspects of intestinal mucus and mucins. Nat Rev Immunol. 2016;16:639-649. [PMID: 27498766 DOI: 10.1038/nri.2016.88] [Cited by in Crossref: 277] [Cited by in F6Publishing: 243] [Article Influence: 55.4] [Reference Citation Analysis]
68 Kawakami S, Ito R, Maruki-Uchida H, Kamei A, Yasuoka A, Toyoda T, Ishijima T, Nishimura E, Morita M, Sai M, Abe K, Okada S. Intake of a Mixture of Sake Cake and Rice Malt Increases Mucin Levels and Changes in Intestinal Microbiota in Mice. Nutrients 2020;12:E449. [PMID: 32053963 DOI: 10.3390/nu12020449] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
69 Longman RJ, Douthwaite J, Sylvester PA, Poulsom R, Corfield AP, Thomas MG, Wright NA. Coordinated localisation of mucins and trefoil peptides in the ulcer associated cell lineage and the gastrointestinal mucosa. Gut 2000;47:792-800. [PMID: 11076877 DOI: 10.1136/gut.47.6.792] [Cited by in Crossref: 134] [Cited by in F6Publishing: 134] [Article Influence: 6.4] [Reference Citation Analysis]
70 Johansson ME, Sjövall H, Hansson GC. The gastrointestinal mucus system in health and disease. Nat Rev Gastroenterol Hepatol 2013;10:352-61. [PMID: 23478383 DOI: 10.1038/nrgastro.2013.35] [Cited by in Crossref: 611] [Cited by in F6Publishing: 512] [Article Influence: 76.4] [Reference Citation Analysis]
71 Kaneko K, Kawai K, Kazama S, Murono K, Sasaki K, Yasuda K, Ohtani K, Nishikawa T, Tanaka T, Kiyomatsu T, Hata K, Nozawa H, Ishihara S, Morikawa T, Fukayama M, Watanabe T. Clinical significance of mucinous components in rectal cancer after preoperative chemoradiotherapy. Surg Today 2017;47:697-704. [DOI: 10.1007/s00595-016-1419-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
72 Louvet B, Buisine MP, Desreumaux P, Tremaine WJ, Aubert JP, Porchet N, Capron M, Cortot A, Colombel JF, Sandborn WJ. Transdermal nicotine decreases mucosal IL-8 expression but has no effect on mucin gene expression in ulcerative colitis. Inflamm Bowel Dis. 1999;5:174-181. [PMID: 10453373 DOI: 10.1097/00054725-199908000-00005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
73 Bankole E, Read E, Curtis MA, Neves JF, Garnett JA. The Relationship between Mucins and Ulcerative Colitis: A Systematic Review. J Clin Med 2021;10:1935. [PMID: 33946184 DOI: 10.3390/jcm10091935] [Reference Citation Analysis]
74 Iwashita J, Sato Y, Sugaya H, Takahashi N, Sasaki H, Abe T. mRNA of MUC2 is stimulated by IL‐4, IL‐13 or TNF‐α through a mitogen‐activated protein kinase pathway in human colon cancer cells. Immunol Cell Biol 2003;81:275-82. [DOI: 10.1046/j.1440-1711.2003.t01-1-01163.x] [Cited by in Crossref: 85] [Cited by in F6Publishing: 78] [Article Influence: 4.7] [Reference Citation Analysis]
75 Hinoda Y, Akashi H, Suwa T, Itoh F, Adachi M, Endo T, Satoh M, Xing PX, Imai K. Immunohistochemical detection of MUC2 mucin core protein in ulcerative colitis. J Clin Lab Anal 1998;12:150-3. [DOI: 10.1002/(sici)1098-2825(1998)12:3<150::aid-jcla4>3.0.co;2-d] [Cited by in Crossref: 11] [Article Influence: 0.5] [Reference Citation Analysis]
76 Khatri IA, Ho C, Specian RD, Forstner JF. Characteristics of rodent intestinal mucin Muc3 and alterations in a mouse model of human cystic fibrosis. American Journal of Physiology-Gastrointestinal and Liver Physiology 2001;280:G1321-30. [DOI: 10.1152/ajpgi.2001.280.6.g1321] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
77 Campbell B. Biochemical and Functional Aspects of Mucus and Mucin-Type Glycoproteins. In: Mathiowitz E, Chickering D, Lehr C, editors. Bioadhesive Drug Delivery Systems. CRC Press; 1999. pp. 85-130. [DOI: 10.1201/b14099-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]